ALLE vs TBPH · P/E 21, rev $2.19B vs P/E 7.5, rev $38.4M
Allegion PLC (ALLE) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Allegion PLC (ALLE) is a security & protection services company listed on US.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
ALLE currently screens at market cap $12.71B and trailing P/E 20.7. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the ALLE and TBPH stock pages for the full models.
Not investment advice.